Seiwerth, Ingmar
Plößl, Sebastian
Herzog, Michael
Schilde, Sebastian
Radetzki, Florian
Krämer, Steffen
Rahne, Torsten
Plontke, Stefan K. http://orcid.org/0000-0002-5424-7688
Funding for this research was provided by:
Martin-Luther-Universität Halle-Wittenberg
Article History
Accepted: 12 April 2022
First Online: 9 September 2022
Declarations
:
: I. Seiwerth, S. Plößl, M. Herzog, S. Schilde, F. Radetzki, S. Krämer, T. Rahne and S.K. Plontke declare that they have no conflict of interest related to the submitted work. Outside the submitted work the following financial activities are declared for all authors: Personal consultancies: AudioCure Pharma GmbH, Berlin, Germany (SKP). Institutional research collaborations: MED-EL, Austria (SKP, TR); Cochlear, Australia (SKP, TR); Oticon Medical, Denmark (SKP, TR); Schwabe Arzneimittel, Germany (SKP). Travel support for lectures: MED-EL, Austria (SKP, IS, TR). Honoraria for lectures (personal): Infectopharm, Heppenheim; Merck Serono, Darmstadt; Schwabe Arzneimittel, Karlsruhe, Germany, MED-EL, Germany (SKP).
: All described procedures or retrospective analyses on humans were conducted in accordance with the institutional ethics committee, with national law and with the 1975 Helsinki declaration and its later amendments.
: The supplement containing this article is not sponsored by industry.